Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy. (Q38962983)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Youqing Shen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Xinpeng Ma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Caitlin J Murphy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Erlei Jin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Qihang Sun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Edward A Van Kirk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

William J Murdoch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

English

0 references

publication date

25 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

Angewandte Chemie International Edition

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

10949-10955

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25155439%20AND%20SRC:MED&resulttype=core&format=json

A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Triazine dendrimers as drug delivery systems: from synthesis to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Poly(amidoamine) dendrimer complexes as a platform for gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Controlled and sustained release of drugs from dendrimer-nanoparticle composite films.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Biomedical applications of dendrimers: a tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Therapeutic and diagnostic applications of dendrimers for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Dendrimers as carriers for delivery of chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

pH-responsive size-tunable self-assembled DNA dendrimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Facile synthesis of polyester dendrimers from sequential click coupling of asymmetrical monomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Understanding ligand distributions in modified particle and particlelike systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Supramolecular nanostructures formed by anticancer drug assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Chain-shattering polymeric therapeutics with on-demand drug-release capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Disulfide cross-linked phosphorylcholine micelles for triggered release of camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Degradation of camptothecin-20(S)-glycinate ester prodrug under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Challenges in design of translational nanocarriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Targeted charge-reversal nanoparticles for nuclear drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

Facile Synthesis of Polyester Dendrimers as Drug Delivery Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442

An Amphiphilic Dendrimer for Effective Delivery of Small Interfering RNA and Gene Silencing In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201406442